Chemed Corporation (NYSE:CHE) Given Consensus Rating of "Hold" by AnalystsMarket Beat·4 hours agoCHE-1.08%
Biotech Stocks At 52-Week Highs - ANIK & CHE Rise With Q2 Results, ICUI, NBIX, RPRXrttnews·6 hours agoANIK+8.10%CHE-1.08%
CHE: 2025 revenue grew 4.1% to $2.53B, but adjusted net income and EPS declined year-over-yearQuartr·1 day ago, 11:08 PMCHE-1.08%
CHE: Strong VITAS results and share buybacks drove higher earnings and raised full-year guidanceQuartr·1 day ago, 03:33 PMCHE-1.08%
Chemed Q2 FY26 GAAP diluted EPS climbs 43.7% to $5.13; revenue increases 8.8% to $673.3 millionPUBT·1 day ago, 03:32 PMCHE-1.08%
Chemed Corporation $CHE Stock Position Cut by NewEdge Wealth LLCMarket Beat·2 days ago, 03:41 AMCHE-1.08%
Janney Montgomery Scott LLC Sells 3,618 Shares of Chemed Corporation $CHEMarket Beat·Jul 11 at 08:37 AMCHE-1.08%
Chemed Corporation (NYSE:CHE) Receives Consensus Recommendation of "Hold" from AnalystsMarket Beat·Jul 5 at 05:14 AMCHE-1.08%